GENinCode (LON:GENI) Sets New 52-Week Low – Should You Sell?

GENinCode Plc (LON:GENIGet Free Report)’s stock price reached a new 52-week low during trading on Thursday . The stock traded as low as GBX 3 ($0.04) and last traded at GBX 3.10 ($0.04), with a volume of 629877 shares trading hands. The stock had previously closed at GBX 3.15 ($0.04).

GENinCode Price Performance

The firm has a market capitalization of £5.50 million, a price-to-earnings ratio of -0.90 and a beta of 0.66. The company has a current ratio of 2.60, a quick ratio of 15.89 and a debt-to-equity ratio of 9.28. The business has a 50-day moving average price of GBX 3.71 and a two-hundred day moving average price of GBX 4.40.

About GENinCode

(Get Free Report)

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies.

Featured Articles

Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.